ARCHIVES

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 46 | December 18, 2009

Download PDF Visit The Full Archive

Related Articles

Boyd Steps Down As DTP Director, Returns to Research

February 16, 1990

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989

Breast Implants Don’t Cause Tissue Disorders, NCI Finds

October 29, 2004

In Brief; NCAB Goes Along With NCI Staff In Funding EORTC Statistical Center Grant Out Of Priority Sequence

November 20, 1981

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974

Study Finds Nearly Two-Thirds Of Children Return to Hospital Following Stem Cell Transplant

April 26, 2013